United Therapeutics Corp.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $463.4M | $2.33B | $1.02B |
| FY2017 | $758.4M | $2.88B | $705.1M |
| FY2018 | $593.2M | $3.40B | $669.2M |
| FY2019 | $1.13B | $3.91B | $738.4M |
| FY2020 | $1.22B | $4.62B | $738.7M |
| FY2021 | $1.21B | $5.17B | $894.8M |
| FY2022 | $1.25B | $6.04B | $961.2M |
| FY2023 | $1.18B | $7.17B | $1.21B |
| FY2024 | $920.0M | $7.36B | $1.70B |
| FY2025 | $783.8M | $7.88B | $1.56B |